Noven Pharmaceuticals, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Aug 24, 2026
  • Last warning letter 2016
Inspections 14 2 OAI
Recalls 51 0 Class I (0%)
Warning letters 2 Latest Aug 5, 2016
510(k) clearances 0 None on file

Noven Pharmaceuticals, Inc. has 51 FDA recalls, 14 inspections, 0 510(k) clearances and 2 compliance actions on record. FDA has issued 2 warning letters to Noven Pharmaceuticals, Inc., the most recent on Aug 5, 2016.

What these totals cover: FDA records filed under the name "Noven Pharmaceuticals, Inc." and its spelling variant "Noven Pharmaceuticals".

Latest recall
D-0055-2025 · Class II · Oct 31, 2024
Latest inspection
Aug 24, 2026 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls51Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections14Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions2Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Noven Pharmaceuticals, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Noven Pharmaceuticals, Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 5 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 7 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 1 inspection (0 OAI), 0 warning letters, 10 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 4 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202620000
202500000
202400010
202300040
202200030
2021100100
202000000
201900000
201810070
201700050

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Noven Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Noven Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Noven Pharmaceuticals, Inc. FDA Warning Letters

2 warning letters from Aug 25, 2011 to Aug 5, 2016.

IssuedSubjectIssuing officeClose-out letter
Aug 5, 2016 · Record page
Aug 25, 2011 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

51 recall records from Jul 5, 2011 to Oct 31, 2024. Showing the 20 most recent. View all 51 recall records

NumberClassProductDate
D-0055-2025Class IIXelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually…Oct 31, 2024
D-0471-2023Class IIDaytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for…Mar 10, 2023
D-0470-2023Class IIDaytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for…Mar 10, 2023
D-0472-2023Class IIDaytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for…Mar 10, 2023
D-0473-2023Class IIDaytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for…Mar 10, 2023
D-0071-2023Class IIDaytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches…Nov 16, 2022
D-1169-2022Class IIDaytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30…Jun 24, 2022
D-0889-2022Class IIDaytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30…May 6, 2022
D-0724-2021Class IICombipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice…Jul 30, 2021
D-0725-2021Class IICombipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day 50/250 Twice…Jul 30, 2021
D-0394-2021Class IIDaytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), 30 Patches…May 20, 2021
D-0393-2021Class IIDaytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches…May 20, 2021
D-0337-2021Class IIEstradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, Mfd. by: Noven…Apr 16, 2021
D-0336-2021Class IIMinivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only, Mfd. by…Apr 16, 2021
D-0295-2021Class IIDaytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) Contains: 30…Feb 19, 2021
D-0294-2021Class IIDaytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), Contains: 30…Feb 19, 2021
D-0293-2021Class IIDaytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), Contains: 30…Feb 19, 2021
D-0296-2021Class IIDaytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) Contains: 30…Feb 19, 2021
D-1208-2018Class IIMinivelle (estradiol transdermal system) Patches, Delivers 0.05 mg/day, a) 2 count and 8 count…Sep 7, 2018
D-1207-2018Class IIMinivelle (estradiol transdermal system) Patches Delivers 0.1 mg/day, a) 2 count and b) 8 count…Sep 7, 2018

Recent FDA inspections

14 inspections from Feb 6, 2009 to Aug 24, 2026.

DateSiteProductClassificationFEI
Aug 24, 2026Miami, FLDrugsVoluntary Action Indicated (VAI)1000222037
Feb 13, 2026Miami, FLDrugsNo Action Indicated (NAI)1000222037
Nov 17, 2021Miami, FLDrugsVoluntary Action Indicated (VAI)1000222037
Jan 26, 2018Miami, FLDrugsVoluntary Action Indicated (VAI)1000222037
Jan 13, 2016New York, NYDrugsNo Action Indicated (NAI)3008855976
Jul 10, 2015Miami, FLDrugsOfficial Action Indicated (OAI)1000222037
Apr 24, 2013Carlsbad, CADrugsNo Action Indicated (NAI)3005201285
Mar 6, 2013New York, NYDrugsNo Action Indicated (NAI)3008855976
Sep 24, 2012Miami, FLDrugsNo Action Indicated (NAI)1000222037
Aug 2, 2012Carlsbad, CADrugsNo Action Indicated (NAI)3005201285
Jun 4, 2012Miami, FLDrugsNo Action Indicated (NAI)1000222037
Feb 14, 2011Carlsbad, CADrugsOfficial Action Indicated (OAI)3005201285
May 6, 2010Miami, FLDrugsVoluntary Action Indicated (VAI)1000222037
Feb 6, 2009Miami, FLDrugsNo Action Indicated (NAI)1000222037
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 2 compliance actions under Noven Pharmaceuticals, Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Aug 5, 2016.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

3 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1000222037Miami, FL9Aug 24, 2026
FEI 3008855976New York, NY2Jan 13, 2016
FEI 3005201285Carlsbad, CA3Apr 24, 2013

Noven Pharmaceuticals, Inc. and the FDA: common questions

Has Noven Pharmaceuticals, Inc. received an FDA warning letter?

Yes. FDA has issued 2 warning letters to Noven Pharmaceuticals, Inc.. The most recent is dated Aug 5, 2016.

Has Noven Pharmaceuticals, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Noven Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Noven Pharmaceuticals, Inc.?

The most recent FDA inspection on file ended Aug 24, 2026 at Miami, FL and was classified VAI. FDA has 14 inspections of Noven Pharmaceuticals, Inc. on file, 2 of them classified OAI (official action indicated).

Has Noven Pharmaceuticals, Inc. had an FDA recall?

Yes. Noven Pharmaceuticals, Inc. has 51 FDA recalls on record. The most recent started Oct 31, 2024.

Need more than this page shows? Ask about Noven Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.